If you’ve searched for Byte aligners recently and something felt off—no way to place an order, confusing notices, reviews that don’t match what you’re seeing now—there’s a clear reason for that. Byte, the at-home clear aligner company, is no longer operating as it once did.
This article breaks down exactly what happened, where things stand as of 2026, and what it means if you’re a current customer or someone who was considering at-home aligners.
What Byte Was and How It Got Here
Byte was a direct-to-consumer (DTC) clear aligner company. The pitch was simple: skip the orthodontist’s office, take impressions at home, mail them in, and receive custom aligners. No in-person visits required.
The model attracted cost-conscious consumers who wanted straighter teeth without traditional orthodontic fees. It gained serious traction, enough that Dentsply Sirona—one of the largest dental products companies in the world—acquired Byte and positioned it as a growth play in the DTC oral care market.
From the start, dental professionals pushed back. The concern was straightforward: patients weren’t being examined in person, which meant conditions that would disqualify someone from aligner treatment could go undetected. That concern turned out to be central to what happened next.
The October 2024 Suspension and What Triggered It
On October 24, 2024, Dentsply Sirona voluntarily suspended all sales and marketing for Byte aligners and impression kits. This wasn’t an FDA enforcement action. Dentsply initiated the pause itself, after reviewing medical device injury reports and consulting with regulators.
What did the internal review find? Byte’s patient onboarding process may not have done enough to screen out contraindicated patients—people for whom aligner treatment was medically inappropriate. In plain terms, some customers who shouldn’t have been treated may have received aligners anyway.
Shipments stopped. New and recently placed orders were paused. Dentsply also disclosed that earlier in 2024, it had begun retroactively reporting a backlog of injuries tied to Byte aligners that had not been previously submitted to regulators.
This wasn’t a supply chain issue or a temporary cash flow problem. It was a regulatory and safety review with serious implications for the entire business model.
Byte’s Full Shutdown in 2025 and the Half-Billion Dollar Write-Off
The October 2024 pause was not a brief interruption. By January 2025, Dentsply confirmed it would not reinstate Byte’s at-home aligner system for new patients. The company began talking about repositioning the brand toward dentist-supervised treatment instead—a fundamentally different model from what Byte had built its customer base on.
Then in February 2025, Dentsply recorded approximately $495 million in impairment charges tied to Byte. That number matters. In accounting terms, an impairment charge of that size means the company formally recognized that the Byte business had lost most of its value. This wasn’t a paper adjustment—it reflected a real decision to walk away from the business.
Dentsply publicly disclosed it was shutting down Byte entirely. The company flagged increased remediation costs and lowered its earnings forecasts as a result. The Byte trademark was written off, which is about as clear a signal as you can get that the brand is not expected to return in its original form.
On top of the regulatory and financial damage, a federal court allowed lawsuits related to Byte injuries to proceed. That legal pressure added another layer of urgency to Dentsply’s decision to close the business down rather than attempt to rebuild it.
To put this in broader business terms: Dentsply acquired a fast-growing DTC health startup, found it carrying significant regulatory liability, and made the call to write it off rather than absorb the ongoing risk. This is a pattern seen in other health-adjacent tech acquisitions—the original business model becomes untenable, and the parent company cuts its losses.
Is Byte Still Operating in 2026?
The short answer is no. Byte is not accepting new at-home aligner customers as of 2026. This is not a backorder situation or a temporary pause. The business model has been shut down.
Reporting from The Age in Australia confirmed that Byte ceased operations and was shut down globally, leaving customers without the ongoing support they expected. Multiple sources—including dental review publications and orthodontic practices—describe Byte as no longer available to new patients.
It’s worth being precise here: Dentsply Sirona as a parent company is still operating. They make and sell other dental products. The shutdown applies specifically to the Byte at-home aligner product line. Dentsply didn’t go bankrupt—it made a deliberate business decision to end Byte.
Some limited support was extended to existing patients who weren’t identified as contraindicated during the wind-down period, but that support is transitional, not a continuation of normal business.
What Current Byte Customers Should Do
If you’re mid-treatment or recently ordered from Byte, here’s what actually makes sense to do right now:
- Get your records. Contact Dentsply directly and request all your treatment records, scans, and documentation. You’ll need these if you continue treatment elsewhere.
- See a dentist or orthodontist in person. Given the concerns about contraindicated patients going unscreened, an in-person evaluation is the right next step—not just to continue treatment, but to confirm your teeth and jaw are in good shape.
- Follow the lawsuits. Ongoing legal proceedings may result in remediation programs or compensation. It’s worth monitoring Dentsply’s official communications and any court updates.
- Don’t assume your current plan is still valid. If your treatment was paused, don’t continue with old aligners without professional sign-off. The whole point of the shutdown was that unsupervised treatment carries real risks.
Refunds, record access, and treatment completion are all legitimate concerns that patients may need to resolve through Dentsply’s customer channels or through legal proceedings. The situation is still evolving in some respects, so staying informed matters.
What This Means for the At-Home Aligner Market
Byte isn’t the first DTC aligner company to run into serious trouble. SmileDirectClub—once the biggest name in mail-order aligners—also shut down. The pattern is similar: fast growth, regulatory scrutiny, safety complaints, and a business model that struggles to survive closer examination.
The core problem with the DTC aligner model is structural. Moving orthodontic treatment entirely remote removes the clinical oversight that catches problems early. X-rays, in-person exams, and professional monitoring exist for a reason. When you strip those out to reduce cost and friction, you also strip out the safety net.
Regulatory bodies in the US and internationally have faced criticism for not moving faster to oversee these products. But the market is now correcting in ways that regulation hadn’t fully forced. Liability, injury reports, and consumer backlash are doing what regulatory action hadn’t yet completed.
For entrepreneurs and investors watching this space, Byte is a case study worth understanding. A large acquirer paid a significant premium for a DTC health startup, underestimated the regulatory and liability exposure, and ended up writing off nearly half a billion dollars. The lesson isn’t that DTC health is always a bad idea—it’s that medical device businesses carry risks that don’t show up clearly in early growth metrics.
For more business analysis like this, Liftbusinesspoint covers real-world business decisions, market shifts, and what they mean for professionals and entrepreneurs.
Could Byte Come Back?
Dentsply did mention repositioning Byte toward dentist-supervised treatment at one point. But with the trademark written off and the business wound down, there’s no realistic path for Byte to return in its original form. The DTC at-home model that defined the brand is gone.
If Dentsply builds something new under a different structure—with clinical oversight built in—that would be a different business entirely, not a Byte revival. For now, anyone expecting Byte to reopen should work from the assumption that it won’t.
The Bottom Line
Byte is effectively out of business. The at-home aligner operation has been shut down, the trademark written off, and nearly $500 million in value erased from Dentsply’s books. Regulatory concerns about patient safety drove the initial suspension, and financial and legal pressure sealed the outcome.
If you were a Byte customer, get your records and see a dentist. If you were considering Byte, the option is gone—and the reasons it’s gone are worth understanding before you evaluate any other at-home dental product.
The broader message is simple: when a health product’s business model depends on skipping professional oversight, that model tends to carry more risk than early reviews and marketing materials suggest.
Read Also:
